MOSCOW, Dec 28 (PRIME) -- Several drugs against the coronavirus based on monoclonal antibodies can appear in Russia, head of the Gamaleya research center Alexander Gintsburg told PRIME on Monday.
"It has nothing to do with the vaccine. It should be called a therapeutic drug to tread COVID patients," Gintsburg said.
He added that Russian companies can absolutely produce several such medicines and several approaches to the research of such drugs are financed.
End
|
|
